InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,354.30
(
0.17%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: None

Friday, 04/21/2023 10:53:50 AM

Friday, April 21, 2023 10:53:50 AM

Post# of 252302
VKTX

Schedule of events

Apr 26 4:30 EST VKTX conference call
Q2: VK2809 P2B results
Q3: VK2735 P2 initiation
Q3: VK0214 X-ALD P1b results
Q4: VK2735 P1 oral results
Q4: VK0214 breakthrough therapy designation(?) (already orphan drug)

Is there anything the fine minds here can add to this in terms of other events (MDGL, other biotech companies, regulatory milestones, approvals, etc.) in any of VKTX's core competencies that might impact the company?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up